NVN1 (Stavzor 250 mg)
Generic Name: valproic acid
Pill imprint NVN1 has been identified as Stavzor 250 mg.
Stavzor is used in the treatment of migraine prevention; seizure prevention; schizoaffective disorder; mania; seizures (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Stavzor 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for NVN1 (Stavzor 250 mg)
- Generic Name:
- valproic acid
- 250 mg
- 14.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Fatty acid derivative anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk - When treating epilepsy
X - Not for use in pregnancy - When treating migraine
- CSA Schedule:
- N - Not a controlled drug
- JDS Pharmaceuticals LLC
- National Drug Code (NDC):
- Inactive Ingredients:
methacrylic acid - methyl methacrylate copolymer (1:1)
FD&C Yellow No. 6
More about Stavzor (valproic acid)
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...